be important to determine if the large, medium and small CR-ip neurons have different connectivity and thus segregate function. Interestingly our results regarding the decreased density of CR-ip interneurons are in line with our previous observations in ASD 1 Background: Genome-wide association studies demonstrated that multiple genetic variants are associated with schizophrenia (SCZ). Additional evidence revealed that genes are prone to operate in functional molecular networks that subtend complex clinical phenotypes. This knowledge raises the need to investigate how genes linked to SCZ and their possible co-regulators are inserted into molecular networks with a key impact in disease pathogenesis. Using post-mortem brain mRNA data sets (Pergola et al. 2017), we have previously identified a co-expression network enriched for SCZ risk genes, including DRD2, the gene coding for the D2 dopamine receptor, and predicted cognitive and neuroimaging phenotypes of SCZ, as well as response to antipsychotic treatment. Given the relevance of DRD2 to the pathophysiology of SCZ, in the current study we sought to further our understanding of biological mechanisms underpinning co-expression of the DRD2 network. In detail, we aimed at probing the hypothesis that expression of genes within the DRD2-related co-expression network is modulated by a common transcriptional regulation involving one or more Transcription factors (TFs). Methods: In order to identify TF binding sites (TFBSs) in the promoter region of the 85 genes belonging to the DRD2 co-expression network, we performed a motif enrichment analysis using Pscan and Genomatix MatInspector tools. Biological validation experiments were performed in primary mouse cortical neurons. By real-time PCR analysis we measured the mRNA transcript levels of a group of genes included in the DRD2 co-expression module in basal conditions and upon viral vector-mediated overexpression (OE) and knockdown (KD) of the predicted TFs. We studied expression of genes linked to either DRD2 in the co-expression gene set, such as Gpld1, Chit1, Btg4 and Osr1, or SCZ risk, such as Gatad2a and Slc28a1. We also analyzed transcript levels of Cnr1, which mediates cannabinoid-induced transmission and is relevant to SCZ. Moreover, we analyzed the transcript levels of D2 long splicing isoform (D2L), which was included in the co-expression network, and D2 short splicing isoform (D2S), to verify whether TF regulation was specific for D2L. Results: Promoters of the DRD2 co-expression gene set were enriched for two TFBSs, recognized by Nur-Related Factor 1 (NURR1, FDR-adjusted p=0.03) and Estrogen-Related Receptor Alpha (ERR1, FDR-adjusted p=0.02), respectively. Validation experiments in mouse primary cortical neurons established that NURR1, and not ERR1, is a regulator of genes of the DRD2 co-expression module analyzed in this study. In detail, Nurr1 gain of function (OE) decreased Cnr1 transcript levels (p=0.0002),
T197. A DRD2 CO-EXPRESSION GENE SET ENRICHED FOR SCHIZOPHRENIA RISK GENES IS CHARACTERIZED BY
Background: Genome-wide association studies demonstrated that multiple genetic variants are associated with schizophrenia (SCZ). Additional evidence revealed that genes are prone to operate in functional molecular networks that subtend complex clinical phenotypes. This knowledge raises the need to investigate how genes linked to SCZ and their possible co-regulators are inserted into molecular networks with a key impact in disease pathogenesis. Using post-mortem brain mRNA data sets (Pergola et al. 2017), we have previously identified a co-expression network enriched for SCZ risk genes, including DRD2, the gene coding for the D2 dopamine receptor, and predicted cognitive and neuroimaging phenotypes of SCZ, as well as response to antipsychotic treatment. Given the relevance of DRD2 to the pathophysiology of SCZ, in the current study we sought to further our understanding of biological mechanisms underpinning co-expression of the DRD2 network. In detail, we aimed at probing the hypothesis that expression of genes within the DRD2-related co-expression network is modulated by a common transcriptional regulation involving one or more Transcription factors (TFs). Methods: In order to identify TF binding sites (TFBSs) in the promoter region of the 85 genes belonging to the DRD2 co-expression network, we performed a motif enrichment analysis using Pscan and Genomatix MatInspector tools. Biological validation experiments were performed in primary mouse cortical neurons. By real-time PCR analysis we measured the mRNA transcript levels of a group of genes included in the DRD2 co-expression module in basal conditions and upon viral vector-mediated overexpression (OE) and knockdown (KD) of the predicted TFs. We studied expression of genes linked to either DRD2 in the co-expression gene set, such as Gpld1, Chit1, Btg4 and Osr1, or SCZ risk, such as Gatad2a and Slc28a1. We also analyzed transcript levels of Cnr1, which mediates cannabinoid-induced transmission and is relevant to SCZ. Moreover, we analyzed the transcript levels of D2 long splicing isoform (D2L), which was included in the co-expression network, and D2 short splicing isoform (D2S), to verify whether TF regulation was specific for D2L. Results: Promoters of the DRD2 co-expression gene set were enriched for two TFBSs, recognized by Nur-Related Factor 1 (NURR1, FDR-adjusted p=0.03) and Estrogen-Related Receptor Alpha (ERR1, FDR-adjusted p=0.02), respectively. Validation experiments in mouse primary cortical neurons established that NURR1, and not ERR1, is a regulator of genes of the DRD2 co-expression module analyzed in this study. In detail, Nurr1 gain of function (OE) decreased Cnr1 transcript levels (p=0.0002), whereas it increased Gpld1 transcript levels (p=0.03). The transcript levels of these genes showed an opposite expression trend upon Nurr1 KD. D2L (p=0.008), but not D2S, Gatad2a (p=0.00001), Slc28a1 (p=0.0005) and Chit1 (p=0.02) showed significant expression profile changes only upon Nurr1 OE and vice versa. Discussion: NURR1 participates in developmental, differentiation and survival processes of dopaminergic neurons. It is implicated in transcriptional modulation of genes involved in dopaminergic transmission, including DRD2, as well as in behavioral phenotypes related to dopaminergic anomalies and reminiscent of SCZ in animal models. Finally, NURR1 genetic variation has been associated with SCZ. Taken together, our results are consistent with previous literature and with the hypothesis that molecular mechanisms responsible for co-expression in DRD2 network involve transcriptional regulation by NURR1. They also suggest reliability of our DRD2 co-expression network, and add new insights on mechanisms linked to DRD2-related molecular ensembles and to SCZ.
T198. A SCHIZOPHRENIA-LIKE BIRTH SEASONALITY AMONG MATHEMATICIANS AND AN OPPOSITE SEASONALITY AMONG BIOLOGISTS: MORE EVIDENCE IMPLICATING BIMODAL RHYTHMS OF GENERAL BIRTHS
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Background: Based on early-20th century births, a pre-electric illumination time of comparatively normal human exposure to sunlight, studies of schizophrenia (SCZ) found a birth seasonality with two opposite effects: a SCZ-liability peak among subjects born around late-February and an equally significant SCZ-resistance peak among those born six months later, around late-August. We previously investigated this rhythm in connection with a sunlight-dependent bimodal rhythm of general births that, prior to the full advent of electric lighting (but not later), occurred ubiquitously in non-equatorial parts of the world. We found that the SCZliability peak coincided with a first, Feb-Mar peak of general-population births (the GP1) while the SCZ-resistance peak coincided with a second, Aug-Sep peak of those births (the GP2). Moreover, in a study of hand and visual-field preferences among professional baseball players, we found the SCZ-liability, GP1-coincident seasonality among players with preferences denoting cerebral asymmetry "deficits" (CADs) and the SCZ-resistance, GP2-coincident seasonality among those with preferences denoting cerebral asymmetry "excesses." Also, in a study suggested by associations of CADs with artistic abilities, we found the SCZ-liability, GP1-coincident seasonality among groups representing visual, performing and literary art "creators" (VPL-Artists) and the SCZ-resistance, GP2-coincident seasonality among groups representing art critics, historians, curators and other art "observers" (Para-Artists). Together, these findings suggested, as one possibility (but see later), that the SCZ-liability, CAD effects and artistic abilities could all three represent traits genetically or otherwise selected into the GP1 excess population of newborns and out of the GP2 population. The present study of "scientists" was initially aimed at the purported arts/ science antithesis. Methods: Birth seasonalities were examined among early-20th century born American scientists and among yet earlier European biologists and mathematicians.
Results: A group representing 1,925 American scientists showed the SCZresistance, GP2-coincident seasonality. However, this effect proved to be mostly due to biologists because biochemists, chemists, and physicists showed gradually less seasonality while mathematicians suggested an altogether artist-like, GP1-coincident seasonality. This intimation of a biologist-mathematician antithesis was pursued with an investigation of most major figures in the history of the two sciences from the 15th to the early-20th century. The two groups, numbering 576 mathematicians and
